Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.60 |
| ▸ | GRM5 | P41594 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CCR1 | P32246 | 1/20 | 0.46 |
| ▸ | CCR8 | P51685 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
| ▸ | NOS2 | P35228 | 1/20 | 0.43 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.42 |
| ▸ | CTSA | P10619 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29590328 | 1.00 | P2RX7 (0.60) | P2RX7GRM5RAB9AALDH1A1CCR1 | |
| SCHEMBL455687 | 0.85 | KDM4E (0.59) | P2RX7RAB9AALDH1A1KDM4EALOX15 | |
| SCHEMBL31116707 | 0.85 | P2RX7 (0.46) | P2RX7GRM5RAB9AALDH1A1HSP90AA1 | |
| SCHEMBL2237588 | 0.84 | P2RX7 (0.62) | P2RX7GRM5RAB9AALDH1A1CCR1 | |
| SCHEMBL1958309 | 0.84 | P2RX7 (0.62) | P2RX7GRM5RAB9AALDH1A1CCR1 | |
| Hydrochloric Acid SCHEMBL27613793 | 0.83 | KDM4E (0.56) | P2RX7RAB9AALDH1A1KDM4EALOX15 | |
| SCHEMBL6641842 | 0.83 | KDM4E (0.56) | P2RX7RAB9AALDH1A1KDM4EALOX15 | |
| SCHEMBL9937722 | 0.82 | P2RX7 (0.60) | P2RX7GRM5RAB9AALDH1A1CCR1 | |
| SCHEMBL118409 | 0.82 | KDM4E (0.70) | P2RX7GRM5RAB9ACCR1CCR8 | |
| Hydrochloric Acid SCHEMBL28930333 | 0.81 | ALDH1A1 (0.58) | P2RX7RAB9AALDH1A1KDM4EALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 393 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080087-A | Pyridine-imine type metal complex and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-116540465-B | Electrochromic ion storage layer film and preparation method thereof | NINGBO MI RUO ELECTRONIC TECHNOLOGY Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-119101093-A | Nickel (II) picolinate catalyst containing axially flexible cycloalkyl and application thereof in hyperbranched polyethylene lubricating oil synthesis | 合肥烯珩新型催化材料有限公司 | 2024-12-10 | — | — | CN | claimed |
| WO-2024046712-A1 | METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE | Forschungszentrum Jülich GmbH (DE) | 2024-03-07 | — | — | WO | claimed |
| CN-116540465-A | Novel electrochromic ion storage layer film and preparation method thereof | 宁波祢若电子科技有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-108530350-B | Mononuclear Fe (II) spin cross complex and preparation method thereof | 南京大学 | 2022-03-25 | — | — | CN | claimed |
| CN-110423234-B | Thiosemicarbazone derivative containing indole fragment and preparation method and application thereof | 郑州大学 | 2020-06-30 | — | — | CN | claimed |
| CN-110423234-A | Thiosemicarbazone derivative of the segment containing indoles and its preparation method and application | UNIV ZHENGZHOU | 2019-11-08 | — | — | CN | claimed |
| CN-105198799-A | Preparation method of 2-methyl-6-(chloromethyl) pyridine hydrochloride | JIANGSU MENGDE PLATING CHEMICALS CO LTD | 2015-12-30 | — | — | CN | claimed |
| CN-104974078-A | Preparation method of 2-methyl-6-chloromethylpyridinehydrochloride | HUANG RONGHUI | 2015-10-14 | — | — | CN | claimed |
| CN-104327078-A | Novel synthetic method of CDK-4/6 inhibitor | SHANGHAI BOSHI MEDICINE TECHNOLOGY CO LTD | 2015-02-04 | — | — | CN | claimed |
| US-4018910-A | ACETYL- OR BENZOYL- PYRIDINE | FIRMENICH & CIE (CH) | 1977-04-19 | — | — | US | claimed |
| CN-122080087-A | Pyridine-imine type metal complex and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-116540465-B | Electrochromic ion storage layer film and preparation method thereof | NINGBO MI RUO ELECTRONIC TECHNOLOGY Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-122036718-A | ALK5 inhibitor and preparation method and application thereof | 安炎达医药技术(广州)有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260055113-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCER | HOFFMANN-LA ROCHE INC. (US) | 2026-02-26 | — | — | US | disclosed |
| US-3952026-A | FLAVOR ADDITIVE FOR FOODS AND BEVERAGES | FIRMENICH & CIE (CH) | 1976-04-20 | — | — | US | disclosed |
| US-3931245-A | FURYLALKYLTHIOL CARBOXYLATES | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
| US-3931166-A | FLAVORANTS | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
| US-3931246-A | FURYLALKYL-THIOETHERS | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055113-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCER | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS, CLIC1 | P2RX7 2952/4885GRM5 2885/4885RAB9A 2666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.